AbbVie, Inc. (ABBV)
223.93
-1.25
(-0.56%)
USD |
NYSE |
Dec 11, 16:00
223.95
+0.02
(+0.01%)
After-Hours: 20:00
AbbVie Cash from Investing (Quarterly): -3.264B for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Johnson & Johnson | -542.00M |
| Eli Lilly & Co. | -2.983B |
| Merck & Co., Inc. | -283.00M |
| Pfizer Inc. | -2.43B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.024B |
| Cash from Financing (Quarterly) | -4.59B |
| Free Cash Flow | 19.68B |
| Free Cash Flow Per Share (Quarterly) | 3.749 |
| Free Cash Flow to Equity (Quarterly) | 8.381B |
| Free Cash Flow to Firm (Quarterly) | 6.849B |
| Free Cash Flow Yield | 4.96% |